Evidence map›Paper›PMID 32270466›Full record

ArticleCerebellum (London, England)2020

Cerebellar Cognitive Affective Syndrome in Costa da Morte Ataxia (SCA36).

R Martínez-Regueiro, M Arias, R Cruz, B Quintáns, T Labella-Caballero, M Pardo, J Pardo, M García-Murias, A Carracedo, M-J Sobrido and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

R Martínez-RegueiroNeurogenetics Research Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
M AriasNeurogenetics Research Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
R CruzGenomics and Bioinformatics, CiMUS, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
B QuintánsNeurogenetics Research Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
T Labella-CaballeroDoctor Emeritus of SERGAS, Department of Otorhinolaryngology, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
M PardoDepartment of Neurology, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Santiago de Compostela, Spain.
J PardoDepartment of Neurology, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Santiago de Compostela, Spain.
M García-MuriasNeurogenetics Research Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
A CarracedoGenomics and Bioinformatics, CiMUS, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
M-J SobridoNeurogenetics Research Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. ssobrido@gmail.com.ORCID http://orcid.org/0000-0001-7964-4770
M Fernández-PrietoNeurogenetics Research Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
Complejo Hospitalario Universitario de Santiago · ESUniversidade de Santiago de Compostela · ESInstituto de Salud Carlos III · ESCentro de Investigación Biomédica en Red · ES

Funding

Instituto de Salud Carlos III FI14-00510Instituto de Salud Carlos III PI12/00742Instituto de Salud Carlos III PI12/01013
6 · The paper itself

Abstract

SCA36 is an autosomal dominant spinocerebellar ataxia (SCA) affecting many families from Costa da Morte, a northwestern region of Spain. It is caused by an intronic GGCCTG repeat expansion in NOP56. In order to characterize the cognitive and affective manifestations of this cerebellar disease, a group of 30 SCA36 mutation carriers (11 preataxic and 19 ataxic patients) were assessed with a comprehensive battery of standardized tests. Phonological verbal fluency - but not semantic fluency - was already mildly impaired in preataxic subjects. In ataxic patients, both phonological and semantic fluencies were significantly below normal. Depression, while more frequent and prominent in ataxic patients, was also often present in the preataxic stage. This is the first systematic study supporting the presence of a mild cerebellar cognitive and affective syndrome in SCA36. Routine evaluation of cognitive and emotional spheres in SCA36 patients as well as asymptomatic mutation carriers should allow early detection and timely therapeutic intervention.

Indexed as

AdultAgedCerebellar DiseasesCognition DisordersFemaleHumansMaleMiddle AgedMood DisordersNuclear ProteinsSpinocerebellar AtaxiasNOP56 protein, humanNuclear ProteinsCCASCerebellumNeurodegenerative diseaseSchmahmann syndromeSpinocerebellar ataxia

Identifiers

PMID32270466
OpenAlexW3016003343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.